Ligand Pharmaceuticals Inc logo

Ligand Pharmaceuticals Inc

NEW
STU:LGDN (USA)   Ordinary Shares - Class B
€ 260 (0%) Aug 5
41.05
P/B:
6.08
Market Cap:
€ 5.26B ($ 6.06B)
Enterprise V:
€ 4.96B ($ 5.72B)
Volume:
0
Avg Vol (2M):
112.00
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

AAPL Stock Intrinsic Values - Apple Inc